Search News

News Results

There are 684,193 News Results

Jun 11, 2018

LONDON, June 11, 2018 /PRNewswire/ --

Jul 24, 2018

Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA(TM) (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario

AMSTERDAM, July 24, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data reinforcing the safety and efficacy of switching to SYMTUZA(TM) (D/C/F/TAF) for the...

Aug 1, 2018

Parkinson's Disease Market 2018 by Phase of Development, Type of Treatment, Type of Molecule, Mechanism of Action, Route of Administration, and Leading Players

DUBLIN, Aug. 1, 2018 /PRNewswire/ -- The "Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights" report has been added to

Jun 2, 2017

Further Study of Combination of Eisai's Lenvatinib and Merck's Pembrolizumab in Previously Treated Patients with Metastatic Endometrial Cancer Supported by Interim Analysis of Ongoing Phase 1b/2 Trial

WOODCLIFF LAKE, N.J., June 3, 2017 /PRNewswire/ -- Eisai Inc. today announced interim results from the first evaluable cohort of Study 111, a Phase 1b/2 study investigating lenvatinib (marketed as...

Jun 6, 2017

Equity Strategies Snag All Top 20 Spots on eVestment Global Screening List; UK Users Globally Focused

ATLANTA, June 7, 2017 /PRNewswire/ -- All 20 of the most popular investment products viewed in May by institutional investment professionals using eVestment were equity focused in May 2017, according...

Jul 6, 2017

Deadline to Acquire BeamReach Solar Intellectual Property Extended

NEW YORK, July 7, 2017 /PRNewswire/ -- OB Realty, LLC, an affiliate of Opus Bank, the former secured lender to BeamReach Solar, is pleased to announce that since April, it...

Jul 9, 2017

Global Next Generation Sequencers - Clinical Diagnostics

NEW YORK, July 10, 2017 /PRNewswire/ --

Jul 9, 2017

Global Acute Myeloid Leukemia (AML) Therapeutics - Pharmaceuticals

NEW YORK, July 10, 2017 /PRNewswire/ --

Jul 24, 2017

Eisai Submits Supplemental New Drug Application to FDA for Lenvatinib in First-Line Hepatocellular Carcinoma

WOODCLIFF LAKE, N.J., July 25, 2017 /PRNewswire/ -- Eisai Inc. today announced it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the...

Sep 9, 2017

Combination of Lenvatinib and Pembrolizumab Results in Notable Response Rates for Patients with Advanced Renal Cell Carcinoma Based on Interim Analysis of Ongoing Phase 1b/2 Trial

WOODCLIFF LAKE, N.J., Sept. 10, 2017 /PRNewswire/ -- Eisai Inc. today announced interim results from the advanced renal cell carcinoma (RCC) cohort of Study 111, a Phase 1b/2 study investigating...

Stories of the day

Sep 9, 2025
Elbit Systems Launches Frontier: Next-Generation AI-Based System to Tackle...
Presented for the first time at the DSEI 2025 exhibition, Frontier is built to autonomously detect, classify, and assess threats in real-time.
Sep 9, 2025
Maxar Partners with Anduril to Power U.S Army’s Mixed-Reality Combat System
This system requires detailed, accurate and up-to-date 3D maps to serve as the spatial foundation for intelligence flowing into the system.
Sep 10, 2025
HENSOLDT offers Spexer radar as naval solution
The naval version focuses on the detection and defence against drones at sea. In addition, the Spexer radar scans the sea surface for anti-ship missiles and submarine periscopes.
Sep 10, 2025
QinetiQ’s Uncrewed Aerial Target milestone showcases sovereign capability
The Phoenix Jet is designed, built, and sustained at QinetiQ’s Advanced Manufacturing Centre in Nowra, New South Wales, home to a local workforce of more than 150 employees, supported by 43 Australian suppliers.